Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL267648

PEFLOXACIN
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21

Basic Information

ChEMBL ID CHEMBL267648
Name PEFLOXACIN
Phase Phase II
Structure Type MOL
InChI Key FHFYDNQZQSQIAI-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

1589 RB 1589-RB EU-5306 Pefloxacin Pefloxacine Pefloxacino
0
Targets
2
Activities
1
Assay Types
11
PK Parameters
20
Publications
6
Known Names
1
Indications
2
Mechanisms

Molecular Properties

333.4
MW (Da)
1.61
ALogP
5
HBA
1
HBD
65.8
PSA (Ų)
0.92
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Achiral
USAN Stem -oxacin
USAN Year 1981

Extended Properties

Molecular Formula C17H20FN3O3
MW 333.36
Aromatic Rings 2
Heavy Atoms 24
NP-Likeness -1.11

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Bacterial DNA gyrase inhibitor INHIBITOR Bacterial DNA gyrase
Topoisomerase IV inhibitor INHIBITOR Topoisomerase IV

Indications

Bacterial Infections

ATC Classification

J01MA03
pefloxacin
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIBACTERIALS FOR SYSTEMIC USE

Activity Summary

IC50 2 meas.

Pharmacokinetic Data

Parameter Value Units Species
CL 5.0 mL.min-1.g-1 Homo sapiens
CL 2.0 mL.min-1.kg-1 Homo sapiens
CL 1.9 mL.min-1.kg-1 Homo sapiens
CL 2.0 mL.min-1.kg-1 Homo sapiens
CL 2.0 mL.min-1.kg-1 Homo sapiens
F 91.25 % Eutheria
F 95.0 % Homo sapiens
Fu 0.75 - Homo sapiens
Fu 0.75 - Homo sapiens
MRT 13.0 hr Homo sapiens
T1/2 11.0 hr Homo sapiens

Literature References

PubMed DOI Target Context # Activities
18725440 10.1128/aac.00082-08 Streptococcus pneumoniae 38
17470656 10.1128/aac.00143-07 Escherichia coli 15
15646539 10.1016/s0399-8320(04)95062-2 Unchecked 11
15646539 10.1016/s0399-8320(04)95062-2 NON-PROTEIN TARGET 8
20070106 10.1021/jm901371v Homo sapiens 8
18644958 10.1128/aac.00638-08 Escherichia coli 6
19822706 10.1128/aac.00733-09 ADMET 6
3007757 10.1021/jm00154a003 Mus musculus 6
2498519 10.1021/jm00126a028 Staphylococcus aureus 6
18086852 10.1128/aac.00732-07 Acinetobacter baumannii 6
3005575 10.1021/jm00153a015 DNA topoisomerase 2-beta 6
1732554 10.1021/jm00080a023 Mus musculus 5
2498519 10.1021/jm00126a028 Escherichia coli 5
29360043 10.1016/j.ejmech.2018.01.039 Plasmodium falciparum 4
16019946 10.1080/00498250400028197 ADMET 4
18426954 10.1124/dmd.108.020479 ADMET 4
1732554 10.1021/jm00080a023 Escherichia coli 4
16078842 10.1021/jm050035f No relevant target 4
17325221 10.1128/aac.01282-06 Mycobacterium leprae 4
3275778 10.1021/jm00396a035 Escherichia coli 4

Data from ChEMBL 36 via Core Engine